BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18444924)

  • 21. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.
    Wu T; Levay-Young B; Heuss N; Sozen H; Kirchhof N; Sutherland DE; Hering B; Guo Z
    Transplantation; 2002 Jul; 74(1):22-7. PubMed ID: 12134094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
    Leventhal JR; Ildstad ST
    Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical islet transplantation at the University of Alberta--the Edmonton experience.
    Truong W; Lakey JR; Ryan EA; Shapiro AM
    Clin Transpl; 2005; ():153-72. PubMed ID: 17424733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
    Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
    Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes.
    Zhang C; Wang M; Racine JJ; Liu H; Lin CL; Nair I; Lau J; Cao YA; Todorov I; Atkinson M; Zeng D
    Diabetes; 2010 Sep; 59(9):2228-36. PubMed ID: 20530743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of donor-specific tolerance to islet allografts in nonhuman primates.
    Gaur LK; Kennedy E; Nitta Y; Nepom GT; Nelson KA; Allen M; Lernmark A
    Ann N Y Acad Sci; 2002 Apr; 958():194-8. PubMed ID: 12021105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.
    Gallon L; Mathew JM; Bontha SV; Dumur CI; Dalal P; Nadimpalli L; Maluf DG; Shetty AA; Ildstad ST; Leventhal JR; Mas VR
    J Am Soc Nephrol; 2018 Feb; 29(2):423-433. PubMed ID: 29191961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
    Leventhal JR; Mathew JM; Ildstad S; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
    Clin Transpl; 2013; ():145-56. PubMed ID: 25095503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
    Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
    Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed chimerism and split tolerance: mechanisms and clinical correlations.
    Al-Adra DP; Anderson CC
    Chimerism; 2011; 2(4):89-101. PubMed ID: 22509425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
    Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
    Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of bone marrow transplantation on type I diabetes.
    Domenick MA; Ildstad ST
    World J Surg; 2001 Apr; 25(4):474-80. PubMed ID: 11344401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
    Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
    Duran-Struuck R; Sondermeijer HP; Bühler L; Alonso-Guallart P; Zitsman J; Kato Y; Wu A; McMurchy AN; Woodland D; Griesemer A; Martinez M; Boskovic S; Kawai T; Cosimi AB; Yang YG; Hu Z; Wuu CS; Slate A; Mapara M; Baker S; Tokarz R; D'Agati V; Hammer S; Pereira M; Lipkin WI; Wekerle T; Levings M; Sykes M
    Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.